These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 7657797)

  • 1. Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption.
    Greenfield EM; Shaw SM; Gornik SA; Banks MA
    J Clin Invest; 1995 Sep; 96(3):1238-44. PubMed ID: 7657797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation by parathyroid hormone of interleukin-6 and leukemia inhibitory factor expression in osteoblasts is an immediate-early gene response induced by cAMP signal transduction.
    Greenfield EM; Horowitz MC; Lavish SA
    J Biol Chem; 1996 May; 271(18):10984-9. PubMed ID: 8631918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of dual signal transduction systems in the stimulation of osteoclast-like cell formation by parathyroid hormone and parathyroid hormone-related peptide.
    Kaji H; Sugimoto T; Kanatani M; Fukase M; Chihara K
    Biochem Biophys Res Commun; 1993 Jul; 194(1):157-62. PubMed ID: 8392835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cytokine expression in osteoblasts by parathyroid hormone: rapid stimulation of interleukin-6 and leukemia inhibitory factor mRNA.
    Greenfield EM; Gornik SA; Horowitz MC; Donahue HJ; Shaw SM
    J Bone Miner Res; 1993 Oct; 8(10):1163-71. PubMed ID: 8256653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
    Hill PA; Reynolds JJ; Meikle MC
    Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo demonstration that parathyroid hormone and parathyroid hormone-related protein stimulate expression by osteoblasts of interleukin-6 and leukemia inhibitory factor.
    Pollock JH; Blaha MJ; Lavish SA; Stevenson S; Greenfield EM
    J Bone Miner Res; 1996 Jun; 11(6):754-9. PubMed ID: 8725172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow cells produce soluble factors that inhibit osteoclast activity.
    Ninomiya JT; Bi Y; Banks MA; Lavish SA; Goldberg VM; Greenfield EM
    J Orthop Res; 1999 Jan; 17(1):51-8. PubMed ID: 10073647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone.
    McSheehy PM; Chambers TJ
    Endocrinology; 1986 Feb; 118(2):824-8. PubMed ID: 3455914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of interleukin-6 receptor activation on intracellular signaling and bone resorption by isolated rat osteoclasts.
    Moonga BS; Adebanjo OA; Wang HJ; Li S; Wu XB; Troen B; Inzerillo A; Abe E; Minkin C; Huang CL; Zaidi M
    J Endocrinol; 2002 Jun; 173(3):395-405. PubMed ID: 12065229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: synergy with dexamethasone.
    Richards CD; Langdon C; Deschamps P; Pennica D; Shaughnessy SG
    Cytokine; 2000 Jun; 12(6):613-21. PubMed ID: 10843736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro.
    Saleh H; Eeles D; Hodge JM; Nicholson GC; Gu R; Pompolo S; Gillespie MT; Quinn JM
    Endocrinology; 2011 May; 152(5):1911-22. PubMed ID: 21363931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of electromagnetic stimulation on the functional responsiveness of isolated rat osteoclasts.
    Shankar VS; Simon BJ; Bax CM; Pazianas M; Moonga BS; Adebanjo OA; Zaidi M
    J Cell Physiol; 1998 Sep; 176(3):537-44. PubMed ID: 9699506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption.
    McSheehy PM; Chambers TJ
    Endocrinology; 1986 Oct; 119(4):1654-9. PubMed ID: 3463505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of parathyroid hormone (PTH) and PTH-related peptide on osteoclast resorption of bone slices in vitro: an analysis of pit size and the resorption focus.
    Murrills RJ; Stein LS; Fey CP; Dempster DW
    Endocrinology; 1990 Dec; 127(6):2648-53. PubMed ID: 2249618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboxyl-terminal parathyroid hormone fragments stimulate osteoclast-like cell formation and osteoclastic activity.
    Kaji H; Sugimoto T; Kanatani M; Miyauchi A; Kimura T; Sakakibara S; Fukase M; Chihara K
    Endocrinology; 1994 Apr; 134(4):1897-904. PubMed ID: 8137758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small bone-building fragments of parathyroid hormone: new therapeutic agents for osteoporosis.
    Whitfield JF; Morley P
    Trends Pharmacol Sci; 1995 Nov; 16(11):382-6. PubMed ID: 8578607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of osteoclast differentiation by local factors.
    Suda T; Udagawa N; Nakamura I; Miyaura C; Takahashi N
    Bone; 1995 Aug; 17(2 Suppl):87S-91S. PubMed ID: 8579904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are osteoblastic cells required for the control of osteoclast activity by parathyroid hormone?
    Jilka RL
    Bone Miner; 1986 Sep; 1(4):261-6. PubMed ID: 2849485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemia inhibitory factor/differentiation-stimulating factor (LIF/D-factor): regulation of its production and possible roles in bone metabolism.
    Ishimi Y; Abe E; Jin CH; Miyaura C; Hong MH; Oshida M; Kurosawa H; Yamaguchi Y; Tomida M; Hozumi M
    J Cell Physiol; 1992 Jul; 152(1):71-8. PubMed ID: 1618924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen stimulates the elaboration of cell/matrix surface-associated inhibitory factor of osteoclastic bone resorption from osteoblastic cells.
    Ishii T; Saito T; Morimoto K; Takeuchi Y; Asano S; Kumegawa M; Ogata E; Matsumoto T
    Biochem Biophys Res Commun; 1993 Mar; 191(2):495-502. PubMed ID: 8461006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.